Gamida Cell Ltd.

01/13/2022 | Press release | Distributed by Public on 01/13/2022 17:26

Amendment to Initial Statement of Beneficial Ownership (Form 3/A)

Ownership Submission
FORM 3/A
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104Expires:January 31, 2005Estimated average burden hours per response...0.5
1. Name and Address of Reporting Person *
Access Industries Holdings LLC
2. Date of Event Requiring Statement (Month/Day/Year)
2022-01-01 		3. Issuer Name and Ticker or Trading Symbol
Gamida Cell Ltd. [GMDA]
(Last) (First) (Middle)
40 WEST 57TH ST, 28TH FL ,
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
5. If Amendment, Date Original Filed(Month/Day/Year)
2022-01-11
(Street)
NEW YORK NY 10019
6. Individual or Join/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security 2. Amount of Securities Beneficially Owned 3. Ownership Form: Direct (D) or Indirect (I) 4. Nature of Indirect Beneficial Ownership
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security 2. Date Exercisable and Expiration Date 3. Title and Amount of Securities Underlying Derivative Security 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) 6. Nature of Indirect Beneficial Ownership
Date Exercisable Expriation Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Access Industries Holdings LLC
40 WEST 57TH ST, 28TH FL

NEW YORK, NY10019
X

Clal Biotechnology Industries Ltd.
3 AZRIELI CENTER TRIANGLE TOWER,
45TH FLOOR, 132 MENACHEM BEGIN ST.
TEL AVIV, L36702301


Affiliate of 10% Owner
Bio Medical Investment (1997) Ltd.
3 AZRIELI CENTER TRIANGLE TOWER,
45TH FLOOR, 132 MENACHEM BEGIN ST.
TEL AVIV, L36702301


Affiliate of 10% Owner
ACCESS INDUSTRIES, LLC
40 WEST 57TH ST, 28TH FL

NEW YORK, NY10019
X

ACCESS INDUSTRIES MANAGEMENT, LLC
40 WEST 57TH ST, 28TH FL

NEW YORK, NY10019
X

Blavatnik Len
40 WEST 57TH ST, 28TH FL

NEW YORK, NY10019
X

AI Gamida Holdings LLC
40 WEST 57TH ST, 28TH FL

NEW YORK, NY10019


Affiliate of 10% Owner

Signatures

/s/ Alejandro Moreno for Access Industries Holdings LLC 2022-01-13
**Signature of Reporting Person Date
/s/ Ofer Gonen (CEO) and Assaf Segal (CFO) for Clal Biotechnology Industries Ltd. 2022-01-13
**Signature of Reporting Person Date
/s/ Ofer Gonen (Director) and Assaf Segal (Director) for Bio Medical Investment (1997) Ltd. 2022-01-13
**Signature of Reporting Person Date
/s/ Alejandro Moreno for Access Industries, LLC 2022-01-13
**Signature of Reporting Person Date
/s/ Alejandro Moreno for Access Industries Management, LLC 2022-01-13
**Signature of Reporting Person Date
/s/ Alejandro Moreno, as Attorney-in-Fact for Mr. Blavatnik 2022-01-13
**Signature of Reporting Person Date
/s/ Alejandro Moreno for AI Gamida Holdings LLC 2022-01-13
**Signature of Reporting Person Date

Explanation of Responses:

(*) If the form is filed by more than one reporting person, see Instruction 5(b)(v).
(**) Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.